Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00680576 · ClinicalTrials.gov registry record · Phase 1

Adolescent Substance Abuse: Progressive Treatment

A Phase 1 study, sponsored by Oregon Research Institute.

Completed
Registry status
Phase 1
Development phase
140
Enrollment target

NCT00680576 is a Phase 1 study that has completed, run by Oregon Research Institute. The registered enrollment target is 140 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00680576, a Phase 1 study, has completed, sponsored by Oregon Research Institute.

COMPLETED
Registry status
Phase 1
Development phase
140 participants
Enrollment target

Study Summary

The purpose of this study is to find out more about how to provide effective further treatment for adolescents who have received six weeks of group therapy for substance-use problems and continue to use drugs. Treatments used in the study include a group therapy (MET/CBT), an individual therapy (CBT), and a family therapy (FFT). The study will look at whether abstinence or a very low level of use is a better guide for deciding whether further treatment is needed, how well different combinations of treatment work to reduce substance use, and whether it is possible to predict in advance which adolescents will respond best to which types of treatment. Study investigators expect that a treatment strategy using what is learned about these issues in the first half of the project to develop an "adaptive" treatment model will work better than a "fixed" treatment to reduce adolescent substance use.

Interventions

  • BEHAVIORAL CBT, Cognitive Behavioral Therapy
  • BEHAVIORAL FFT, Family Functional Therapy

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2008-03
Est. Completion 2013-08
Phase Phase 1

Sponsor

Oregon Research Institute

62 total trials

What the Registry Record Tells You About NCT00680576

The ClinicalTrials.gov registry entry for NCT00680576 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Research Institute, which has 62 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which CBT, Cognitive Behavioral Therapy is the first listed.

NCT00680576 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00680576 about?

NCT00680576 is a clinical study titled "Adolescent Substance Abuse: Progressive Treatment". The purpose of this study is to find out more about how to provide effective further treatment for adolescents who have received six weeks of group therapy for substance-use problems and continue to use drugs. Treatments used in the study include a group therapy (MET/CBT), an individual therapy (CBT...

What is the current status of trial NCT00680576?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 140 participants. The study started on 2008-03. Estimated completion is 2013-08.

What interventions are being tested in trial NCT00680576?

The interventions under investigation include: CBT, Cognitive Behavioral Therapy (BEHAVIORAL), FFT, Family Functional Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00680576?

This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.